EUVIMEDEUVIMED entdecken
Crossref

Antibody status at delivery and pregnancy outcomes during the first Danish COVID-19 wave

Victoria Holten Springborg, Julie Milbak, Sissil Egge, Jane Marie Bendix, Nanna Vinterberg, Ida LA Ammitzbøll, Claus Aj Jensen, Paul Bryde Axelsson, Ellen Christine Leth Løkkegaard, Line Rode, Tine Dalsgaard Clausen

Danish Medical Journal · 2024

DOI: 10.61409/a10230657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Danish Medical Journal, 2024. Verfasst von Victoria Holten Springborg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Copenhagen University Hospital - North Zealand, Hilleroed. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious, Pregnancy Outcome, Antibodies, Viral. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION. We aimed to investigate the prevalence of SARS-CoV-2 infection and SARS-CoV-2 antibodies in parturient women and their newborns during the first Danish COVID-19 wave and to identify associations with maternal background characteristics, self-reported symptoms, and pregnancy outcomes. METHODS. In a single-centre, prospective cohort study from Denmark, we invited 1,883 women with singleton pregnancies giving live birth from 25 May 2020 to 2 November 2020. Hereof, 953 (50.6%) women were included. Nasopharyngeal swabs, maternal and umbilical cord blood samples, and questionnaires were collected. Medical records were available for participants and non-participants. RESULTS. SARS-CoV-2 antibodies were found in 1.3% of the women. All newborns of seropositive women had SARS-CoV-2 antibodies in cord blood. No association was found between SARS-CoV-2 antibodies and pregnancy outcomes. Self-reported loss of smell correlated with seropositivity (p < 0.001). No women were hospitalised due to COVID-19 during pregnancy or had a positive nasopharyngeal swab intrapartum. CONCLUSIONS. The prevalence of COVID-19 in pregnancy was low during the first wave. Maternal SARS-CoV-2 antibodies were associated with antibodies in cord blood, loss of smell and positive SARS-CoV-2 swab during pregnancy, but not with any adverse pregnancy outcomes. FUNDING. Ferring Pharmaceuticals funded part of the study. TRIAL REGISTRATION. The study was approved by the Regional Committee on Health Research Ethics (H-20028002) and the Danish Data Protection Agency (P-2020-264).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pregnancy Complications, InfectiousPregnancy OutcomeAntibodies, ViralSARS-CoV-2HumansPregnancyFemaleDenmarkAdultProspective StudiesInfant, NewbornFetal BloodPrevalence

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Copenhagen University Hospital - North Zealand, Hilleroed.
  • Department of Clinical Biochemistry, Copenhagen University Hospital - North Zealand, Hilleroed.
  • Department of Clinical Medicine, University of Copenhagen, 4) Department of Clinical Biochemistry.
  • Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.

Zitieren

APA

Springborg, V. H., Milbak, J., Egge, S., Bendix, J. M., Vinterberg, N., Ammitzbøll, I., Jensen, C. A., Axelsson, P. B., Løkkegaard, E. C. L., Rode, L., & Clausen, T. D. (2024). Antibody status at delivery and pregnancy outcomes during the first Danish COVID-19 wave. Danish Medical Journal. https://doi.org/10.61409/a10230657

Vancouver

Springborg VH, Milbak J, Egge S, Bendix JM, Vinterberg N, Ammitzbøll I, et al. Antibody status at delivery and pregnancy outcomes during the first Danish COVID-19 wave. Danish Medical Journal. 2024. doi:10.61409/a10230657

BibTeX
@article{Springborg2024,
  author = {Springborg, Victoria Holten and Milbak, Julie and Egge, Sissil and Bendix, Jane Marie and Vinterberg, Nanna and Ammitzbøll, Ida LA and Jensen, Claus Aj and Axelsson, Paul Bryde and Løkkegaard, Ellen Christine Leth and Rode, Line and Clausen, Tine Dalsgaard},
  title = {Antibody status at delivery and pregnancy outcomes during the first Danish COVID-19 wave},
  journal = {Danish Medical Journal},
  year = {2024},
  doi = {10.61409/a10230657}
}
Kostenlos starten →